Sign in
8-K

Current Report

LENZ Therapeutics, Inc. Filed Acc 0000950170-23-044135

Exit or restructuring costs · Executive or director change · Other events

  • Item 2.05 Costs associated with exit or disposal activities
  • Item 5.02 Departure or appointment of directors or officers
  • Item 8.01 Other events

From the SEC's structured data for this filing

Loading grph-20230818.htm…